Prospective Observation for Serial Changes in Acute Intracranial Artery Dissection Using HR-MRI
1 other identifier
interventional
20
1 country
1
Brief Summary
Intracranial artery disease has been more detected with development of HR-MR. HR-MR can depict vascular wall directly and give us more information beyond the pre-existing imaging modalities such as digital subtraction angiography, magnetic resonance angiography, computed tomography angiography. Hence, HR-MR is considered to become promising imaging modality for intracranial artery disease and many studies have been published recently. However, there was not enough to differentiate various intracranial artery disease such as atherosclerosis, dissection, moyamoya disease, vasculitis, reversible vasoconstriction syndrome. In real clinical arena, intracranial artery disease is too difficult to diagnose and distinguish among the disease. Of the disease, usefulness of HR-MR has been consistently published in the detection and diagnosis of intracranial artery dissection recently. HR-MR seems to be the most important and reliable imaging method in intracranial artery dissection as of now. Therefore, intracranial artery dissection is necessary to study using HR-MR. Intracranial artery dissection is dynamic vascular pathology. The geometric change is the most common among intracranial artery disease. However, there was no report about the geometric change in HR-MR. The investigators acquired retrospective data about the natural course of intracranial artery dissection in HR-MR and are preparing for publishing an article. However, the data is not prospective and not intraindividual comparison. Therefore, reliability is not enough to convince the natural course. If the investigators got prospective and intraindividual data, definite natural course of intracranial artery dissection could be acquired and would be helpful to diagnose the dissection and differentiate from other vascular pathologies. The longitudinal information from this study could guide us as the important map on the confusing HR-MR findings. In addition, the previous retrospective study can be a stepping-stone to perform a prospective study, which can increase the success rate of the prospective study. The protocols for imaging follow-up are as followed: initial (optional), 1 month, 3 month, 6 month (optional), 12 month
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 7, 2017
CompletedFirst Posted
Study publicly available on registry
July 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 7, 2019
CompletedDecember 20, 2019
December 1, 2019
3.3 years
July 7, 2017
December 18, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Prospective observation for serial changes in acute intracranial artery dissection using HR-MRI
Radiological findings of HR-MRI during the study period
The time interval from initial event to outcome measurement is 1 year.
Study Arms (1)
Intracranial artery dissection
OTHERPatients with intracranial artery dissection who were diagnosed based on the clinical and radiological (including MRI) diagnoses at the symptom onset after Jan-01-2016
Interventions
Eligibility Criteria
You may qualify if:
- Informed consent
- Acute intracranial artery dissection
You may not qualify if:
- angioplasty, or stenting,
- contraindication for MR imaging,
- Hypersensitivity to gadolinium based contrast media,
- Pregnant or lactating women,
- Renal condition : eGFR \< 60, 6) Patients unable and/or unwilling to comply with treatment or study instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Asan Medical Centerlead
- Ministry of Health & Welfare, Koreacollaborator
- Bracco Corporatecollaborator
Study Sites (1)
Asan Medical Center
Seoul, 138-736, South Korea
Related Publications (2)
Park KJ, Jung SC, Kim HS, Choi CG, Kim SJ, Lee DH, Suh DC, Kwon SU, Kang DW, Kim JS. Multi-Contrast High-Resolution Magnetic Resonance Findings of Spontaneous and Unruptured Intracranial Vertebral Artery Dissection: Qualitative and Quantitative Analysis According to Stages. Cerebrovasc Dis. 2016;42(1-2):23-31. doi: 10.1159/000444315. Epub 2016 Mar 8.
PMID: 26950228RESULTJeong SY, Jung SC, Roh YH, Kwon SU, Kang DW, Kim JS, Choi KM, Kim S, Jeong E. Serial changes and optimal imaging windows in vessel wall MRI for unruptured intracranial artery dissection. Sci Rep. 2025 Jul 1;15(1):21864. doi: 10.1038/s41598-025-05732-4.
PMID: 40596300DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seung Chai Jung, Professor
Associate professor, Department of Radiology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD. PhD.
Study Record Dates
First Submitted
July 7, 2017
First Posted
July 11, 2017
Study Start
January 1, 2016
Primary Completion
April 7, 2019
Study Completion
April 7, 2019
Last Updated
December 20, 2019
Record last verified: 2019-12